Cardiac surgery
Our cardiac surgery destination for education, evidence, and innovation. We update our information and features frequently. Check back for upcoming physician news and stories.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Listen. Learn. Connect. And be inspired.
Dr. Martin shares his considerations for assessing mitral regurgitation.
Check our training programs, roundtable discussions, and education resources for the treatment of mitral and tricuspid diseases.
Grand Rounds are interactive global webcasts delivered by industry-leading experts on a wide range of relevant topics. Listen to Drs. Bavaria and Klautz discuss Today's SAVR Patient: Case Based Discussions Valve Design and Impact on Clinical Outcomes.
Rediscover pediatric VV ECMO.
You spoke. We listened.
Only physicians with previous training and experience with venous catheterization and extracorporeal life support should use this device.
A design platform for long-term durability. Interior-mounted leaflets that leverage our proprietary AOA™ tissue treatment.
No clinical data is available which evaluates the long-term impact of AOA treatment in patients.
A complete portfolio of rigid, semi-rigid, and flexible annuloplasty products designed specifically for a more physiological mitral and tricuspid valve repair.
Aortic, mitral, bovine, and porcine tissue; stented, stentless, and mechanical — we have a full portfolio to meet your needs.
Beating heart procedures and sicker coronary patients — we can help you find the right procedure for the right patient.
Innovative and proven, a complete portfolio to optimize your circuit and blood product utilization.
Unmatched selection of cannulae — pediatric and adult — to facilitate insertion and drainage techniques.
Your mission is our mission — providing you with products designed for ECMO.
Achieve transmural lesions with temperature-controlled ablation systems.
A video library of MICS techniques and approaches.
Maximum equipment UPTIME. You expect it, patients rely on it, and we deliver it.
Stay up to date with new products, innovative stories, and events:
Get the latest cardiac surgery updates from Medtronic.
CardioVascular LifeLine
877-526-7890
rs.structuralheart@medtronic.com
View our education and training materials for more information.
™*Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
Crescent™* RA jugular dual lumen catheter is manufactured by MC3, Inc. and exclusively distributed by Medtronic. Crescent™* RA jugular dual lumen catheters are not approved in every geography.
Tadokoro N, Fukushima S, Shimahara Y, et al. Comparison of safety and haemodynamic performance between the Avalus™ stented aortic valve bioprosthesis and Magna™ valve in Japanese patients. Gen Thorac Cardiovasc Surg. July 2021;69(7):1060-1069.
The latest results of the Perigon Study, presented by Prof. Dr. Robert J.M. Klautz during EACTS 2021: Surgical Aortic Valve Replacement with a Stented Pericardial Bioprosthesis: 5-year Outcomes. The PERIGON Pivotal Trial regarding the Avalus valve is a prospective, interventional, nonrandomized, worldwide, multi-site trial, with each center following a common protocol. The study was designed in accordance with the recommendations of the EN ISO 5840:2009 standard for cardiac valve prostheses and the U.S. Food and Drug Administration (FDA) Heart Valve Guidance (2010; DRAFT) and conducted in accordance with the Declaration of Helsinki and good clinical practice guidelines. Valve-related events and deaths were adjudicated by an independent clinical events committee (CEC). All study echocardiograms were analyzed by an independent core laboratory (MedStar Health Research Institute, Washington, D.C.). Safety oversight was provided by an independent data and safety monitoring board (DSMB). This trial is registered at www.clinicaltrials.gov, NCT02088554.